Skip to content
OpenCapital
Get started

Assembly Biosciences ASMB Enterprise value

Enterprise value at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$8.7B+418%
ALN
Alnylam PharmaceuticalsALNY
$42.43B+24.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$315.24M+909%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$856.58M+35.5%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$1.24B+102%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$519.22M+44.6%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K—
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity0×-0.1×
Current ratio6.6×+4.6×

Where this comes from

Calculated from Assembly Biosciences’s reported figures.

$440.2Mmarket cap+$2.5Mtotal debt−$31.1Mcash and equivalents=$411.56M

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's enterprise value?
Assembly Biosciences (ASMB) reported enterprise value of $411.56M in Q1 2026.
How has Assembly Biosciences's enterprise value changed year-over-year?
Assembly Biosciences's enterprise value increased by 701.6% year-over-year, from $51.34M to $411.56M.
What is the long-term trend for Assembly Biosciences's enterprise value?
Over 5 years (2020 to 2025), Assembly Biosciences's enterprise value has grown at a 14.9% compound annual growth rate (CAGR), from $240.25M to $482.12M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.